CNS Disorders  >>  methylprednisolone oral  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylprednisolone oral / Generic mfg.
COMTiMS, NCT01305837 / 2010-024561-43: Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis

Completed
2
30
Europe
methylprednisolone, Medrol
Rigshospitalet, Denmark
Progressive Multiple Sclerosis
07/13
07/13
IMPACT-2, NCT06215261: An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD

Not yet recruiting
2
79
RoW
Methylone, Placebo
Transcend Therapeutics
Post Traumatic Stress Disorder
12/25
12/25
IMPACT-EXT, NCT06237426: An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD

Enrolling by invitation
2
150
Europe
Methylone
Transcend Therapeutics
Post Traumatic Stress Disorder
05/27
05/27
NCT01046786: Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord

Completed
1/2
8
RoW
Umbilical Cord Blood Mononuclear Cell, Methylprednisolone, Lithium
China Spinal Cord Injury Network, Chinese University of Hong Kong, The University of Hong Kong
Spinal Cord Injuries
10/13
12/13
NCT04219995: Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy

Unknown status
1/2
10
US
methylprednisolone sodium succinate, Placebo
Louisiana State University Health Sciences Center in New Orleans
Intractable Epilepsy, Convulsive Seizures
02/21
02/21
IMPACT-1, NCT05741710: A Study to Assess the Use of Methylone in the Treatment of PTSD

Recruiting
1/2
79
Europe
Methylone, Placebo
Transcend Therapeutics
Post Traumatic Stress Disorder
12/24
12/24

Download Options